IMMUCELL CORPORATION -
4.9900
13-May-25 15:50:31
15 minutes delayed
Stocks
-0.2500
-4.77%
Today's range
4.7784 - 5.2800
ISIN
N/A
Source
NASDAQ
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024
09 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: IMMUCELL CORPORATION - COMMON STOCK
21 Jun 2024 09:45:21 By NetDania Notify
-
NetDania - New 12 months Low: IMMUCELL CORPORATION - COMMON STOCK
17 Jun 2024 13:17:07 By NetDania Notify
-
NetDania - New 12 months Low: IMMUCELL CORPORATION - COMMON STOCK
13 Jun 2024 10:14:37 By NetDania Notify
-
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
05 Jun 2024 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
04 Jun 2024 16:05:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: IMMUCELL CORPORATION - COMMON STOCK
04 Jun 2024 09:45:38 By NetDania Notify
-
NetDania - New 12 months Low: IMMUCELL CORPORATION - COMMON STOCK
31 May 2024 12:04:29 By NetDania Notify
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
14 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024
08 May 2024 13:00:48 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
09 Apr 2024 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
27 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
16 Feb 2024 09:30:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
08 Jan 2024 16:05:22 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
13 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
07 Nov 2023 12:15:19 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
05 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Submission of CMC Technical Section to the FDA
29 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
10 Aug 2023 16:05:01 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
07 Aug 2023 12:00:00 By Nasdaq GlobeNewswire